Compare WIW & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WIW | BVS |
|---|---|---|
| Founded | 2004 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 529.9M | 482.9M |
| IPO Year | N/A | 2016 |
| Metric | WIW | BVS |
|---|---|---|
| Price | $8.64 | $8.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.33 |
| AVG Volume (30 Days) | ★ 252.0K | 249.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 11.14% | N/A |
| EPS Growth | N/A | ★ 79.12 |
| EPS | N/A | ★ 0.12 |
| Revenue | N/A | ★ $573,280,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $6.78 |
| P/E Ratio | ★ N/A | $73.29 |
| Revenue Growth | N/A | ★ 11.89 |
| 52 Week Low | $8.33 | $5.81 |
| 52 Week High | $9.03 | $11.25 |
| Indicator | WIW | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 54.31 |
| Support Level | $8.49 | $7.04 |
| Resistance Level | $8.84 | $9.01 |
| Average True Range (ATR) | 0.07 | 0.32 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 24.44 | 51.01 |
Western Asset Inflation-Linked Opportunities and Income Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to provide current income. Capital appreciation, when consistent with current income, is a secondary investment objective. The fund operates as a single operating segment, which is an investment portfolio.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.